KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Short-term Investments (2016 - 2025)

Biogen has reported Short-term Investments over the past 16 years, most recently at $807.2 million for Q4 2025.

  • Quarterly results put Short-term Investments at $807.2 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $807.2 million (changed N/A YoY), and the annual figure for FY2025 was $807.2 million, changed.
  • Short-term Investments for Q4 2025 was $807.2 million at Biogen, up from $97.6 million in the prior quarter.
  • Over the last five years, Short-term Investments for BIIB hit a ceiling of $3.5 billion in Q2 2023 and a floor of $97.6 million in Q3 2025.
  • Median Short-term Investments over the past 4 years was $1.4 billion (2021), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Short-term Investments: crashed 32.63% in 2021 and later soared 64.37% in 2022.
  • Biogen's Short-term Investments stood at $1.5 billion in 2021, then fell by 4.39% to $1.5 billion in 2022, then soared by 134.85% to $3.5 billion in 2023, then plummeted by 76.67% to $807.2 million in 2025.
  • The last three reported values for Short-term Investments were $807.2 million (Q4 2025), $97.6 million (Q3 2025), and $3.5 billion (Q2 2023) per Business Quant data.